Clinical Trials

Oncology Research - Clinical Trials

The J. Phillip Citta Cancer Center provides patients access to national and regional clinical research studies. The availability of these studies in the treatment of cancer, chemoprevention, and supportive care allow patients the option to participate in the latest treatment options including investigational drugs.

For more information, please call

Jonathan A. Gapilango RN MSN OCN
Director, Oncology Research & Oncology Data Ctr
J. Phillip Citta Regional Cancer Center
Community Medical Center

(732) 557-8239 office
(732) 557-8599 fax

Open Protocol List as of April 24, 2017

Breast Clinical Trials

A011104 / 6694

Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer

CK-SAPBI

A Multi-Institutional Registry for CyberKnife Stereotactic Accelerated Partial Breast Irradiation

NRG BR003

NRG-BR003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

Lung Clinical Trials

Lung Cancer Screening Registry

The ACR Lung Screening Registry (LCSR) is designed to systematically audit the quality of interpretation of screening lung CT exams

RTOG 1306

A Randomized Phase II study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)

A151216

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)

A081105

A Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

E4512

A Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for patients with tumors harboring the ALK fusion protein

EA5142

EA5142: Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)

A Randomized Phase III Study of Nivolumab after Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers

BioDyn-15-003

Evaluation of the TR(ACE)® Assay for the Ability to Aid in Monitoring Disease Progress, Response to Therapy or for the Recurrent or Residual Disease for Patients with Previously Diagnosed Cancers (Stage III and IV Lung )

Colon Clinical Trial

NSABP Protocol C-13

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib following completion of standard Chemotherapy for Patients with Stage III colon cancer (ARGO)

Cyberknife Clinical Trials

RSSSearch Patient Registry Protocol

An international, multi-center ongoing database designed to standardize the collection of data on the use of stereotactic surgery (SRS)/ stereotactic body radiation therapy (SBRT) systems in everyday practice

UPMC #09-031

Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for Low and Intermediate Risk Prostate Cancer

NJCK 12-01

Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for High Risk Prostate Cancer

UPCI 10-027

Phase II Study For Curative Intent Treatment got Patients with Oligometastatic disease at Initial Presentation

UPCI # 10-028

“Phase II Study of Stereotactic Radiosurgery / Stereotactic Body Radiation Therapy for Patients with Oligo-Recurrent Disease

[ top ]